Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


EU a step closer to defining nanomaterials

This article was originally published in SRA

Executive Summary

The European Commission has launched a public consultation on the definition of the term "nanomaterials" now that its Scientific Committee on Emerging and Newly Identified Health Risks (SCENIHR) has published a preliminary opinion on the matter1,2. The consultation aims to achieve a science-based working definition, which is viewed as critical for the development of policy and regulatory activities on nanotechnologies, including nanomedicine. The deadline for submitting comments is 15 September.




Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts